Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk

Insomnia, dizziness, headache and other central nervous system side-effects are occurring more frequently with everyday use of dolutegravir than clinical trials had suggested, and are most likely to

Published
25 October 2016
By
Keith Alcorn
Mental health disorders common among people with HIV in British Columbia

Over 50% of people with HIV, many from disenfranchised groups, in British Columbia, Canada, are living with a mental health disorder, investigators report in AIDS Care. Such disorders

Published
18 October 2016
By
Michael Carter
We could prevent millions of cancer deaths with knowledge we already have

Cutting-edge breakthroughs are still vital in medicine, but we have many ways to prevent and cure cancer that aren’t globally accessible – but should be.

Published
18 October 2016
From
The Guardian
Heart- and age-related issues

New issue of TreatmentUpdate focused on cardiovascular health.

Published
12 October 2016
From
CATIE
Less than 100% adherence to HIV therapy, even with viral suppression, can lead to more inflammation and immune activation

Research involving men taking antiretroviral therapy, all with an undetectable viral load, has shown that imperfect adherence to therapy is associated with higher levels of key markers of

Published
12 October 2016
By
Michael Carter
No evidence that contaminated nelfinavir led to increased risk of birth abnormalities or cancer

HIV-negative infants potentially exposed in utero to doses of the HIV protease inhibitor nelfinavir (Viracept) contaminated with the toxic compound ethyl methyl sulfone (EMS) did not have an

Published
10 October 2016
By
Michael Carter
Promising trends continue in UK diagnosis and treatment rates

A ‘mini report’ of the latest figures on HIV diagnoses, late diagnosis, and treatment uptake in the UK reports generally good results, with downward trends in infections, the

Published
07 October 2016
By
Gus Cairns
Stigma and empty wallets make HIV positive people carry on despite pain

Up to three quarters of people living with HIV suffer from pain. The Conversation Africa spoke to Antonia Wadley about research that measured activity and resilience among people living with HIV and pain.

Published
03 October 2016
From
The Conversation
6 Nursing Homes Accused of HIV Discrimination

The facilities allegedly refused to accept a client because of his HIV, according to the ACLU.

Published
22 September 2016
From
Poz
Ask A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya or Odefsey?

I’ve heard more than a few patients ask, what should I do? If I’m already taking Complera, Stribild or Truvada, should I switch to the newer drug formulation with tenofovir alafenamide (TAF)?

Published
20 September 2016
From
BETA blog

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.